Edwards Lifesciences appoints Theodora Mistras as CFO, effective May 29, 2026

Edwards Lifesciences Corp

Theodora Mistras appointed CFO effective May 29, 2026, succeeding Scott Ullem (announced October transition).
Compensation: $925K base salary, $2.013M sign-on bonus (pro-rata clawback within 24 months), $8M RSUs (vesting over 3 years).
Mistras was previously CFO of Viatris (since March 2024) and held senior roles at Citigroup and Goldman Sachs in healthcare IB.
She is eligible for severance of at least 1x base salary plus 1x target bonus, pro-rated bonus, and $50K outplacement.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Theodora Mistras

Corporate Vice President, Chief Financial Officer

EW · Edwards Lifesciences Corp

Effective: 2026-05-29
Filed: May 4, 2026, 7:59 PM ET

On May 4, 2026, Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), announced that Theodora Mistras has been appointed as the Corporate Vice President, Chief Financial Officer of the Company, effective May 29, 2026, to succeed Scott B. Ullem in that position.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Theodora Mistras was appointed as Corporate Vice President, Chief Financial Officer at Edwards Lifesciences Corp.

Action: appointed
Role: Corporate Vice President, Chief Financial Officer

Exact text from the filing

On May 4, 2026, Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), announced that Theodora Mistras has been appointed as the Corporate Vice President, Chief Financial Officer of the Company, effective May 29, 2026, to succeed Scott B. Ullem in that position.

View on SEC.gov

Edwards Lifesciences Corp filing history →

Source: SEC EDGAR

accession 0001099800-26-000023

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.